enVVeno Medical (NVNO) Return on Capital Employed Growth (3y) (2021 - 2026)
enVVeno Medical (NVNO) Return on Capital Employed Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1,679.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -846.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1,318.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -247.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | enVVeno Medical | 2.75 Mn | 2.75 Mn | - | -838.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -838.00 |
| Dec 31, 2025 | -1,316.00 |
| Sep 30, 2025 | -1,435.00 |
| Jun 30, 2025 | -2,215.00 |
| Mar 31, 2025 | -2,112.00 |
| Dec 31, 2024 | -2,256.00 |
| Sep 30, 2024 | -2,956.00 |
| Jun 30, 2024 | -2,815.00 |
| Mar 31, 2024 | -1,267.00 |
| Dec 31, 2023 | 9,479.00 |
| Sep 30, 2023 | 11,892.00 |
| Jun 30, 2023 | 232,696.00 |
| Mar 31, 2023 | 82,570.00 |
| Dec 31, 2022 | 22,322.00 |
| Sep 30, 2022 | 10,072.00 |
| Jun 30, 2022 | 10,438.00 |
| Mar 31, 2022 | 26,170.00 |
| Dec 31, 2021 | 23,435.00 |